Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2255 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Opko Health wins new US patent

The claims of the newly issued patent cover a broad range of methods of using various small interfering RNAs (siRNAs) that target a sequence of human hypoxia-inducible factor-1alpha

GlaxoSmithKline Q1 profit down

Before major restructuring charges, profit attributable to shareholders was GBP1.33 billion or 26.2 pence per share for the first quarter of 2009, compared to GBP1.37 billion or 25.5